Upon the binding of PD-1 on tumor-infiltrating lymphocytes to PD-L1 on tumor cells, an inhibitory signal is transmitted to T cells, which can block the TCR signal cascade responses and its co-stimulatory signal transduction, inducing dysfunction and even exhaustion of effector T cells, thus causing tumor cell immune escape [74]. This evidence concerns the gene PDCD1 and neoplasm.